← Back to headlines
ImmunityBio Stock Rises Following EU Approval of Bladder Cancer Therapy
ImmunityBio's stock saw an increase after its bladder cancer therapy received approval in the European Union.
18 Feb, 15:06 — 18 Feb, 15:06
ImmunityBio's stock saw an increase after its bladder cancer therapy received approval in the European Union.
18 Feb, 15:06 — 18 Feb, 15:06
